Health New Zealand Te Whatu Ora Shared Care FHIR API
0.4.3 - release

Health New Zealand Te Whatu Ora Shared Care FHIR API - Local Development build (v0.4.3) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

## Questionnaire: Antiviral medication eligibility questionnaire

Official URL: https://build.fhir.org/ig/tewhatuora/cinc-fhir-ig/Questionnaire/AntiViralEligibilityQuestionnaire | Version: 1.0.1
Draft as of 2024-03-22 | Computable Name: AntiViralEligibilityQuestionnaire
Other Identifiers: AntiViralEligibilityQuestionnaire (use: official, period: 3/7/23 --> (ongoing)), Questionnaire-AntiViralEligibilityQuestionnaire (use: temp, period: 3/7/23 --> 3/7/26)
Usage:Workflow Setting:

A questionnaire defining eligibility criteria for anti-viral medication

Assess a patient's eligibility against criteria for anti-viral medication

Structure

LinkID | Text | Cardinality | Type | Flags | Description & Constraints
--- | --- | --- | --- | --- | ---
AntiViralEligibilityQuestionnaire | A questionnaire defining eligibility criteria for anti-viral medication |  | Questionnaire |  | https://build.fhir.org/ig/tewhatuora/cinc-fhir-ig/Questionnaire/AntiViralEligibilityQuestionnaire#1.0.1
CurrentDate | Current Date/Time | 1..1 | dateTime |  |
CurrentDateTime_helpText | Current date/time | 0..1 | display |  |
ReviewDate | Date Review Performed | 1..1 | date |  |
ReviewDate_helpText | The date that the review was performed | 0..1 | display |  |
case-definition-panel | CASE DEFINITION The transition from PCR to RATs as a primary mode of testing requires the clinical criteria to be applied thoughtfully and practically alongside the Case Definition. The case definitions were based upon PCR tests being the primary mode of diagnosis and the focus has now changed to clinical decision making based on a RAT result in the majority of cases. Clinical discretion should be applied to household contacts who test negative by RAT but are presenting with symptoms typical of COVID-19 infection. Although this population is not defined by the Case Definition^, clinical discretion may support recognition as a likely case and initiation of treatment, where indicated. ^For definition see https://www.tewhatuora.govt.nz/for-the-health-sector/covid-19-information-for-health-professionals/case-definition-and-clinical-testing-guidelines-for-covid-19#:~:text=Case%20definitions&text=A%20case%20that%20has%20laboratory,a%20validated%20NAAT%20(PCR) | 0..1 | group |  |
COVID19-Positive | Is the patient a COVID-19 case as per the case definition or clinical criteria? | 1..1 | boolean |  | Initial Value: boolean = false
criteria-panel | Does the patient meet the current Pharmac criteria for COVID-19 Antivitals? | 0..1 | group |  |
SymptomsStart | 1. Symptoms started: | 1..1 | choice |  | Value Set: https://nzhts.digital.health.nz/fhir/ValueSet/antiviral-eligibility-symptoms-started
supoxygen | 2. My patient requires supplemental oxygen | 1..1 | boolean |  |
criteria | 3. My patient's condition or circumstance (choose one): | 1..1 | choice |  | Value Set: https://nzhts.digital.health.nz/fhir/ValueSet/COVID-19-antiviral-eligibility-criteria
myPatientCriteria_helpText | [1]For definition of Ministry of Health criteria of ‘severe immunocompromise’ for third primary dose see: https://www.health.govt.nz/covid-19-novel-coronavirus/covid-19-vaccines/covid-19-vaccine-severely-immunocompromised-people#criteria [2]A primary dose for most people is 2 vaccinations [3]For Ministry of Health's definition of high-risk conditions see https://covid19.govt.nz/testing-and-isolation/if-you-have-covid-19/medicines-to-treat-covid-19/ | 0..1 | display |  |
eligible-no | Assessment: No - the patient IS NOT eligible for COVID-19 Antivirals | 0..1 | choice |  | Enable When: SymptomsStart = supoxygen = criteria = Options: 1 option
eligible-yes | Assessment: Yes - the patient IS eligible for COVID-19 Antivirals | 0..1 | choice |  | Enable When: SymptomsStart != supoxygen != criteria != Options: 1 option
PharmacistInformation | Please provide pharmacist details | 0..1 | group |  |
PharmacistName | Pharmacist Name | 1..1 | string |  |
PharmacistID | Pharmacist ID | 1..1 | string |  |
PharmacyInformation | Please provide details about the pharmacy organisation | 0..1 | group |  |
PharmacyName | Pharmacy Name | 1..1 | string |  |
PharmacyHPI | Pharmacy HPI | 1..1 | string |  |
PharmacyAddress | Pharmacy address details | 0..1 | text |  |
GeneralPracticeInformation | Please provide details about the patient's general practice | 0..1 | group |  |
GPName | GP Practice Name | 0..1 | string |  |
GPEDI | Practice EDI | 0..1 | string |  |
SendToGP | Send note to GP Inbox? | 0..1 | boolean |  | Initial Value: boolean = false
SendToGP_helpText | It may not be necessary to send this message. Please consider if clinically-relevant before sending. | 0..1 | display |  |
Documentation for this format

Options Sets

Answer options for eligible-no

- null#confirm ("confirm")

Answer options for eligible-yes

- null#confirm ("confirm")